These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22487054)

  • 1. Metabolic monosaccharides altered cell responses to anticancer drugs.
    Chen L; Liang JF
    Eur J Pharm Biopharm; 2012 Jun; 81(2):339-45. PubMed ID: 22487054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.
    Almaraz RT; Aich U; Khanna HS; Tan E; Bhattacharya R; Shah S; Yarema KJ
    Biotechnol Bioeng; 2012 Apr; 109(4):992-1006. PubMed ID: 22068462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.
    Saeui CT; Nairn AV; Galizzi M; Douville C; Gowda P; Park M; Dharmarha V; Shah SR; Clarke A; Austin M; Moremen KW; Yarema KJ
    PLoS One; 2018; 13(5):e0195812. PubMed ID: 29847599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel sugar analog enhances sialic acid production and biotherapeutic sialylation in CHO cells.
    Yin B; Wang Q; Chung CY; Bhattacharya R; Ren X; Tang J; Yarema KJ; Betenbaugh MJ
    Biotechnol Bioeng; 2017 Aug; 114(8):1899-1902. PubMed ID: 28295160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Butyrated ManNAc with Glycoengineered CHO Cells Improves EPO Glycan Quality and Production.
    Wang Q; Chung CY; Yang W; Yang G; Chough S; Chen Y; Yin B; Bhattacharya R; Hu Y; Saeui CT; Yarema KJ; Betenbaugh MJ; Zhang H
    Biotechnol J; 2019 Apr; 14(4):e1800186. PubMed ID: 30221828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialic acid glycoengineering using N-acetylmannosamine and sialic acid analogs.
    Moons SJ; Adema GJ; Derks MT; Boltje TJ; Büll C
    Glycobiology; 2019 Jun; 29(6):433-445. PubMed ID: 30913290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells.
    Campbell CT; Aich U; Weier CA; Wang JJ; Choi SS; Wen MM; Maisel K; Sampathkumar SG; Yarema KJ
    J Med Chem; 2008 Dec; 51(24):8135-47. PubMed ID: 19053749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery.
    Mathew MP; Tan E; Shah S; Bhattacharya R; Adam Meledeo M; Huang J; Espinoza FA; Yarema KJ
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6929-33. PubMed ID: 23041156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the cellular uptake and metabolic conversion of acetylated N-acetylmannosamine (ManNAc) analogues to sialic acids.
    Jones MB; Teng H; Rhee JK; Lahar N; Baskaran G; Yarema KJ
    Biotechnol Bioeng; 2004 Feb; 85(4):394-405. PubMed ID: 14755557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Glycoengineering with Azide- and Alkene-Modified Hexosamines: Quantification of Sialic Acid Levels.
    Dold JEGA; Wittmann V
    Chembiochem; 2021 Apr; 22(7):1243-1251. PubMed ID: 33180370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ligand binding to the bifunctional key enzyme in the sialic acid biosynthesis by NMR: II. Investigation of the ManNAc kinase functionality.
    Benie AJ; Blume A; Schmidt RR; Reutter W; Hinderlich S; Peters T
    J Biol Chem; 2004 Dec; 279(53):55722-7. PubMed ID: 15498763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of N-acetyl-D-mannosamine improves age-associated impairment of long-term potentiation in the senescence-accelerated mouse.
    Taniguchi S; Kuwahara M; Ito K
    Neurosci Lett; 2015 Jun; 598():41-6. PubMed ID: 25962821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid.
    Mathew MP; Tan E; Labonte JW; Shah S; Saeui CT; Liu L; Bhattacharya R; Bovonratwet P; Gray JJ; Yarema KJ
    Chembiochem; 2017 Jul; 18(13):1204-1215. PubMed ID: 28218815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialic acid (N-acetyl neuraminic acid) utilization by Bacteroides fragilis requires a novel N-acetyl mannosamine epimerase.
    Brigham C; Caughlan R; Gallegos R; Dallas MB; Godoy VG; Malamy MH
    J Bacteriol; 2009 Jun; 191(11):3629-38. PubMed ID: 19304853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells.
    Kim EJ; Sampathkumar SG; Jones MB; Rhee JK; Baskaran G; Goon S; Yarema KJ
    J Biol Chem; 2004 Apr; 279(18):18342-52. PubMed ID: 14966124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificity of the sialic acid biosynthetic pathway.
    Jacobs CL; Goon S; Yarema KJ; Hinderlich S; Hang HC; Chai DH; Bertozzi CR
    Biochemistry; 2001 Oct; 40(43):12864-74. PubMed ID: 11669623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy.
    Xu X; Wang AQ; Latham LL; Celeste F; Ciccone C; Malicdan MC; Goldspiel B; Terse P; Cradock J; Yang N; Yorke S; McKew JC; Gahl WA; Huizing M; Carrillo N
    Mol Genet Metab; 2017 Sep; 122(1-2):126-134. PubMed ID: 28641925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxicity and MUC1 suppression.
    Aich U; Campbell CT; Elmouelhi N; Weier CA; Sampathkumar SG; Choi SS; Yarema KJ
    ACS Chem Biol; 2008 Apr; 3(4):230-40. PubMed ID: 18338853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementation With the Sialic Acid Precursor N-Acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension.
    Peng J; Vongpatanasin W; Sacharidou A; Kifer D; Yuhanna IS; Banerjee S; Tanigaki K; Polasek O; Chu H; Sundgren NC; Rohatgi A; Chambliss KL; Lauc G; Mineo C; Shaul PW
    Circulation; 2019 Dec; 140(24):2005-2018. PubMed ID: 31597453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic sialosylation of gangliosides in situ in rat brain cortical slices.
    Durrie R; Rosenberg A
    J Lipid Res; 1989 Aug; 30(8):1259-66. PubMed ID: 2769077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.